Selective activation of STAT3 in human monocytes stimulated by G-CSF:: implication in inhibition of LPS-induced TNF-α production

被引:51
作者
Nishiki, S
Hato, F
Kamata, N
Sakamoto, E
Hasegawa, T
Kimura-Eto, A
Hino, M
Kitagawa, S
机构
[1] Osaka City Univ, Sch Med, Dept Physiol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Sch Med, Dept Clin Hematol, Abeno Ku, Osaka 5458585, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2004年 / 286卷 / 06期
关键词
monocytes; granulocyte colony-stimulating factor; interleukin-10; lipopolysaccharide; tumor necrosis factor-alpha; signal transducer and activator of transcription 3;
D O I
10.1152/ajpcell.00387.2003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lipopolysaccharide (LPS) induced tumor necrosis factor (TNF)-alpha production in human monocytes, which was dependent on activation of extracellular signal-regulated kinase (ERK), p38, c-Jun NH2-terminal kinase (JNK), and nuclear factor (NF)-kappaB. LPS-induced TNF-alpha production was inhibited by granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-10. G-CSF, like IL-10, exerted the inhibitory effect even when simultaneously added with LPS. Among the signaling pathways, signal transducer and activator of transcription 3 (STAT3) was selectively activated in monocytes stimulated by G-CSF or IL-10. G-CSF-mediated inhibition of LPS-induced TNF-alpha production as well as G-CSF-induced STAT3 phosphorylation and suppressor of cytokine signaling 3 mRNA expression were prevented by pretreatment of monocytes with AG-490, an inhibitor of Janus kinase 2. G-CSF did not affect LPS-induced activation of ERK, p38, JNK, and NF-kappaB, indicating that G-CSF affects the pathway downstream or independently of these signaling molecules. G-CSF-induced, but not IL-10-induced, STAT3 phosphorylation was attenuated in the presence of LPS. These findings suggest that G-CSF, like IL-10, inhibits LPS-induced TNF-alpha production in human monocytes through selective activation of STAT3, and the immunomodulation observed in vivo by G-CSF administration may be partly ascribed to the direct effect of G-CSF on monocyte functions.
引用
收藏
页码:C1302 / C1311
页数:10
相关论文
共 57 条
[1]   Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways [J].
Ahmed, ST ;
Ivashkiv, LB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5227-5237
[2]   Toll-like receptor signaling pathways [J].
Barton, GM ;
Medzhitov, R .
SCIENCE, 2003, 300 (5625) :1524-1525
[3]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[4]   Analysis of granulocyte colony stimulating factor receptor isoforms, polymorphisms and mutations in normal haemopoietic cells and acute myeloid leukaemia blasts [J].
Bernard, T ;
Gale, RE ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) :527-533
[5]  
Boneberg EM, 2002, EUR J IMMUNOL, V32, P1717, DOI 10.1002/1521-4141(200206)32:6<1717::AID-IMMU1717>3.0.CO
[6]  
2-N
[7]   Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ [J].
Boneberg, EM ;
Hareng, L ;
Gantner, F ;
Wendel, A ;
Hartung, T .
BLOOD, 2000, 95 (01) :270-276
[8]   p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes [J].
Dean, JLE ;
Brook, M ;
Clark, AR ;
Saklatvala, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :264-269
[9]  
DEMETRI GD, 1991, BLOOD, V78, P2791
[10]   Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages [J].
Denys, A ;
Udalova, IA ;
Smith, C ;
Williams, LM ;
Ciesielski, CJ ;
Campbell, J ;
Andrews, C ;
Kwaitkowski, D ;
Foxwell, BMJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4837-4845